Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. (Record no. 9627181)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01881 a2200541 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513145322.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199809s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1420-4096 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1159/000025845 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Haas, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980921 |
245 00 - TITLE STATEMENT | |
Title | Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Kidney & blood pressure research |
Date of publication, distribution, etc. | 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 66-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angiotensin-Converting Enzyme Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Creatinine |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA |
General subdivision | analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enalapril |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hemodynamics |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peptidyl-Dipeptidase A |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymorphism, Genetic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proteinuria |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sodium |
General subdivision | urine |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yilmaz, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schmidt, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Neyer, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arneitz, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stummvoll, H K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wallner, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Auinger, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arias, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schneider, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mayer, G |
773 0# - HOST ITEM ENTRY | |
Title | Kidney & blood pressure research |
Related parts | vol. 21 |
-- | no. 1 |
-- | p. 66-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1159/000025845">https://doi.org/10.1159/000025845</a> |
Public note | Available from publisher's website |
No items available.